Diabetes mellitus associated with immune checkpoint inhibitors treatment: A clinical case by atezolizumab Pablo Rodríguez de Vera Gómez; María del Castillo Tous Romero; Cristóbal Morales Portillo; Isabel Serrano Olmedo; María Asunción Martínez Brocca;

Pembrolizumab-induced dual endocrine disruption: A case report María Carmen Dameto Pons; Elena González Arnáiz; María Antequera González; Xavier F. Pérez Candel; Diana Ariadel Cobo; Javier Castañón Alonso; María D. Ballesteros Pomar;

Subacute De Quervain thyroiditis after SARS-CoV-2 infection María C. Álvarez Martín; Cristina del Peso Gilsanz; Antonio Hernández López;